Test Directory

Test Code
C5393
Test Name
Bartter Syndrome And Related Disorders NGS Panel
CPT Codes
81479
Expected Turnaround Time
Typically 2 to 4 weeks from receipt of a sample in the laboratory. All cases involving ongoing pregnancies will be expedited.
Clinical Utility
Genetic analysis to provide a molecular diagnosis of Bartter syndrome and related disorders. Bartter syndrome is a genetically heterogeneous kidney disorder with defective sodium, potassium and chloride reabsorption in the thick ascending loop of Henle. Recommended for individuals with a personal and/or family history of Bartter syndrome and related disorders to ensure appropriate treatment and establish recurrence risk for family members.
Specimen and Container Info

Non-Prenatal Specimens

Preferred/Alternate

Specimen Type

Containers

Volume

Preferred Specimen Type

Whole Blood

Lavender Top (EDTA)

3 mL

Alternate Specimen Type

Genomic DNA

1.5 mL Tube

3 µg (at a concentration of at least 30 ng/µl), preferably in TE solution.

Alternate Specimen Type

Fibroblasts

T-25 Flasks

2 confluent T-25 flasks, filled to capacity

Alternate Specimen Type

Saliva (Whole blood is recommended for CNV)

DNA Self-Collection Kit or Oragene Saliva Collection Kit for Young Children

Follow kit instructions (www.dnagenotek.com)

Prenatal Specimens

Either specimen type below is acceptable.

Specimen Type

Containers

Volume

Cultured cells

T-25 Flasks

2 confluent T-25 flasks derived from amnio or CVS samples.

Genomic DNA

1.5 mL Tube

3 µg (at a concentration of at least 30 ng/µl), preferably in TE solution.

NOTE: For specimens from outside of North America, the preferred specimen type is Genomic DNA. HNL Genomics does not recommend shipping whole blood or cultured cells from any location other than the United States, Canada, or Mexico.

Transport Instructions
  • Transport at room temperature within 24 hours.
  • If the specimen cannot be transported to the lab within 24 hours, refrigerate for up to 72 hours.
  • Do not freeze or expose to extreme temperatures, refrigerate for up to 72 hours if cannot be transported to lab within 24 hours. 
Stability Requirements

Room Temperature

24 hours

Refrigerated

72 hours

Causes for Rejection
  • Improperly labeled specimen (minimum of two patient identifiers)
  • Inappropriate specimen type
  • Incomplete or incorrect test request form
  • Insufficient volume
  • Specimen has leaked in transit
  • Specimen without a test order
Methodology
Next Generation Sequencing and Copy Number Variation Analysis
Performing Location
Genomics - Snowdrift
Description

Bartter syndrome is a genetically heterogeneous kidney disorder with defective sodium, potassium and chloride reabsorbtion in the thick ascending loop of Henle. Bartter syndrome is divided into two main forms; antenatal and classic Bartter syndrome. The classic form is typically less severe than the antenatal form with the age of onset in early childhood. Depending on the age of onset, severity of the disorder and the gene involved, the clinical findings may consist of polyhydramnios, premature birth, polyuria, polydipsia, muscle weakness, nephrocalcinosis, osteopenia, chondrocalcinosis, and deafness.

Gene

Disorder

MIM

Inheritance

BSND

Bartter syndrome, type 4a (BARTS4A)   

Sensorineural deafness with mild renal dysfunction

602522

602522

AR

AR

CASR

Hypocalcemia, autosomal dominant 1, with Bartter syndrome (HYPOC1)

601198

AD

CLCNKA

Bartter syndrome, type 4b, digenic (BARTS4B)

613090

DR

CLCNKB

Bartter syndrome, type 3 (BARTS3)

Bartter syndrome, type 4b, digenic (BARTS4B)

607364

613090

AR

DR

GNA11

Hypocalcemia, autosomal dominant 2 (HYPOC2)

615361

AD

KCNJ1

Bartter syndrome, type 2 (BARTS2)

241200

AR

MAGED2

Bartter syndrome, type 5, antenatal, transient (BARTS5)

300971

XLR

SLC12A1

Bartter syndrome, type 1 (BARTS1)

601678

AR

SLC12A3

Gitelman syndrome (GTLMNS)

263800

AR

Testing Schedule
Monday-Friday
Genes
BSND, CASR, CLCNKA, CLCNKB, GNA11, KCNJ1, MAGED2, SLC12A1, SLC12A3
Disease Group
Nephrology